Home

Firefly Neuroscience, Inc. - Common Stock (AIFF)

3.3800
-0.1700 (-4.79%)

Firefly Neuroscience, Inc. is a pioneering company focused on developing innovative neurotechnology solutions aimed at enhancing the understanding and treatment of neurological conditions

The firm leverages advanced research and cutting-edge technology to create tools and therapies that enable more precise diagnosis and effective management of brain-related disorders. Through its commitment to scientific excellence and patient-centered approaches, Firefly strives to revolutionize the field of neuroscience, ultimately improving the quality of life for individuals affected by neurological diseases.

SummaryNewsPress ReleasesChartHistoricalFAQ
Dow Gains Over 200 Points; Signet Jewelers Shares Plungebenzinga.com
Via Benzinga · January 14, 2025
Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higherbenzinga.com
Via Benzinga · January 14, 2025
What's Going On With Firefly Neuroscience Stock Tuesday?benzinga.com
Firefly Neuroscience shares are trading higher on Tuesday after the company announced the advancement of research to assess a patient's brain age.
Via Benzinga · January 14, 2025
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In Decemberbenzinga.com
Via Benzinga · January 14, 2025
12 Information Technology Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 30, 2024
12 Information Technology Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 28, 2024
12 Information Technology Stocks Moving In Friday's After-Market Sessionbenzinga.com
Via Benzinga · October 25, 2024
12 Information Technology Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 22, 2024
12 Information Technology Stocks Moving In Friday's Intraday Sessionbenzinga.com
Via Benzinga · October 18, 2024
12 Information Technology Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · October 17, 2024
Firefly Neuroscience And Bright Minds Advance Phase 1 Study With AI-Driven Data Analysisbenzinga.com
Firefly Neuroscience partners with Bright Minds Biosciences to analyze positive Phase 1 data of BMB-101 using advanced AI technology, setting the stage for Phase 2 trials.
Via Benzinga · October 17, 2024
12 Information Technology Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · October 17, 2024
12 Information Technology Stocks Moving In Wednesday's After-Market Sessionbenzinga.com
Via Benzinga · October 16, 2024